{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:15:44Z","timestamp":1790172944429,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.bbr.2013.01.034","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T17:05:12Z","timestamp":1359738312000},"page":"142-151","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat"],"prefix":"10.1016","volume":"244","author":[{"given":"Philip J.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazel","family":"Shabanpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Akhter","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Gundlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.01.034_bib0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.034_bib0010","unstructured":"World Health Organization. The global burden of disease: 2004 update. Geneva: WHO, Press, World Health Organization; 2008."},{"key":"10.1016\/j.bbr.2013.01.034_bib0015","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/npp.2010.161","article-title":"NIMH-funded pragmatic trials: moving on","volume":"35","author":"Wang","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuropharm.2009.12.004","article-title":"From synapse to nucleus: novel targets for treating depression","volume":"58","author":"Covington","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","article-title":"CRF and CRF receptors: role in stress responsivity and other behaviors","volume":"44","author":"Bale","year":"2004","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0030","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/mp.2009.141","article-title":"The CRF system, stress, depression and anxiety-insights from human genetic studies","volume":"15","author":"Binder","year":"2010","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.034_bib0035","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1074\/jbc.M107882200","article-title":"Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family","volume":"277","author":"Bathgate","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.bbr.2013.01.034_bib0040","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1046\/j.1471-4159.2002.01114.x","article-title":"Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain","volume":"82","author":"Burazin","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.bbr.2013.01.034_bib0045","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1460-9568.2005.03980.x","article-title":"Neurons expressing relaxin 3\/INSL 7 in the nucleus incertus respond to stress","volume":"21","author":"Tanaka","year":"2005","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cne.1303","article-title":"Connections of the nucleus incertus","volume":"438","author":"Goto","year":"2001","journal-title":"Journal of Comparative Neurology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cne.10774","article-title":"Cytoarchitecture and efferent projections of the nucleus incertus of the rat","volume":"464","author":"Olucha-Bordonau","year":"2003","journal-title":"Journal of Comparative Neurology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0060","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.neubiorev.2011.02.004","article-title":"Nucleus incertus \u2013 an emerging modulatory role in arousal, stress and memory","volume":"35","author":"Ryan","year":"2011","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.bbr.2013.01.034_bib0065","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1523\/JNEUROSCI.20-03-01142.2000","article-title":"Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system","volume":"20","author":"Bittencourt","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuropharm.2009.06.019","article-title":"Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation","volume":"58","author":"Banerjee","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000083656","article-title":"Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing","volume":"80","author":"Sutton","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuroscience.2006.08.072","article-title":"Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat","volume":"144","author":"Ma","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/npp.2009.109","article-title":"Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety","volume":"35","author":"Davis","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0090","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0095","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1523\/JNEUROSCI.23-25-08788.2003","article-title":"Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide","volume":"23","author":"Lemonde","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejphar.2004.07.038","article-title":"The role of monoamines in the actions of established and \u201cnovel\u201d antidepressant agents: a critical review","volume":"500","author":"Millan","year":"2004","journal-title":"European Journal of Pharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.bbr.2013.01.034_bib0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.bbr.2013.01.034_bib0110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopsych.2009.03.012","article-title":"The serotonin-1A receptor in anxiety disorders","volume":"66","author":"Akimova","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.034_bib0115","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1523\/JNEUROSCI.5836-10.2011","article-title":"Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety","volume":"31","author":"Richardson-Jones","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1460-9568.2008.06333.x","article-title":"Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity","volume":"28","author":"Forster","year":"2008","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.regpep.2007.08.010","article-title":"Developmental expression and serotonergic regulation of relaxin 3\/INSL7 in the nucleus incertus of rat brain","volume":"145","author":"Miyamoto","year":"2008","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.bbr.2013.01.034_bib0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12031-010-9468-0","article-title":"Relaxin-3\/INSL7 regulates the stress\u2013response system in the rat hypothalamus","volume":"43","author":"Watanabe","year":"2011","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.2008.03796.x","article-title":"Relaxin-3 and its role in neuroendocrine function","volume":"1160","author":"McGowan","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.bbr.2013.01.034_bib0140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fnbeh.2011.00050","article-title":"Relaxin-3-deficient mice showed slight alteration in anxiety-related behavior","volume":"5","author":"Watanabe","year":"2011","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1601-183X.2011.00730.x","article-title":"Relaxin-3 null mutation mice display a circadian hypoactivity phenotype","volume":"11","author":"Smith","year":"2012","journal-title":"Genes, Brain and Behavior"},{"key":"10.1016\/j.bbr.2013.01.034_bib0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/mol.104.006700","article-title":"Relaxin-3\/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7","volume":"67","author":"Liu","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0155","article-title":"Relaxin-3 receptor activation in central amygdala enhances fear extinction in the rat: implications for relaxin-3 control of emotion","author":"Ma","year":"2010","journal-title":"Society for Neuroscience \u2013 Abstract"},{"key":"10.1016\/j.bbr.2013.01.034_bib0160","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1021\/jm201505p","article-title":"Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1","volume":"55","author":"Shabanpoor","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bbr.2013.01.034_bib0165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0031-9384(94)90311-5","article-title":"Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety","volume":"56","author":"Belzung","year":"1994","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.bbr.2013.01.034_bib0170","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2013.01.034_bib0175","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0185","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.bbr.2013.01.034_bib0190","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1210\/en.2004-1532","article-title":"Central relaxin-3 administration causes hyperphagia in male Wistar rats","volume":"146","author":"McGowan","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0195","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/bi052233e","article-title":"Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo","volume":"45","author":"Bathgate","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbr.2013.01.034_bib0200","doi-asserted-by":"crossref","first-page":"25425","DOI":"10.1074\/jbc.M701416200","article-title":"R3(B(23-27)R\/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization","volume":"282","author":"Kuei","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.bbr.2013.01.034_bib0205","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.peptides.2010.02.020","article-title":"Centrally administered relaxin-3 induces Fos expression in the osmosensitive areas in rat brain and facilitates water intake","volume":"31","author":"Otsubo","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2013.01.034_bib0210","doi-asserted-by":"crossref","first-page":"23811","DOI":"10.1074\/jbc.M800489200","article-title":"Structure of the R3\/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist","volume":"283","author":"Haugaard-Jonsson","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.bbr.2013.01.034_bib0215","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.bbr.2013.01.034_bib0220","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.ALC.0000131976.40428.8F","article-title":"Anxiety-like behavior in mice in two apparatuses during withdrawal from chronic ethanol vapor inhalation","volume":"28","author":"Kliethermes","year":"2004","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.bbr.2013.01.034_bib0225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/bjp.2008.126","article-title":"Persistent downregulation of hippocampal CREB mRNA parallels a Y-maze deficit in adolescent rats following semi-chronic amphetamine administration","volume":"154","author":"Featherby","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0230","series-title":"Discovering statistics using SPSS","author":"Field","year":"2009"},{"key":"10.1016\/j.bbr.2013.01.034_bib0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0091-3057(95)02171-X","article-title":"The influence of open arm ledges and maze experience in the elevated plus-maze","volume":"54","author":"Fernandes","year":"1996","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.bbr.2013.01.034_bib0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(01)00292-3","article-title":"Factors controlling measures of anxiety and responses to novelty in the mouse","volume":"125","author":"File","year":"2001","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.034_bib0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.bbr.2013.01.034_bib0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-4328(96)00160-X","article-title":"Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light\/dark and dark\/light tests","volume":"85","author":"Chaouloff","year":"1997","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.034_bib0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.bbr.2013.01.034_bib0265","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0270","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nature Protocols"},{"key":"10.1016\/j.bbr.2013.01.034_bib0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0280","doi-asserted-by":"crossref","first-page":"9550","DOI":"10.1523\/JNEUROSCI.19-21-09550.1999","article-title":"Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli","volume":"19","author":"Dulawa","year":"1999","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0285","series-title":"Hodological and functional study of the nucleus incertus and pars alfa of the pontine periventricular gray","author":"Goto","year":"1998"},{"key":"10.1016\/j.bbr.2013.01.034_bib0290","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0031-9384(01)00528-5","article-title":"The use of behavioral test batteries: effects of training history","volume":"73","author":"McIlwain","year":"2001","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.bbr.2013.01.034_bib0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00442247","article-title":"Discovery of antidepressant activity by forced swimming test may depend on pre-exposure of rats to a stressful situation","volume":"97","author":"Borsini","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0300","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.0504011102","article-title":"Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala","volume":"102","author":"Mitra","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bbr.2013.01.034_bib0305","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrn2651","article-title":"Stress, memory and the amygdala","volume":"10","author":"Roozendaal","year":"2009","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0310","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/nn.3234","article-title":"Neurobiology of resilience","volume":"15","author":"Russo","year":"2012","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0315","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1749-6632.2008.03812.x","article-title":"Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system","volume":"1160","author":"Sutton","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.bbr.2013.01.034_bib0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10799890600623373","article-title":"Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats","volume":"26","author":"Hida","year":"2006","journal-title":"Journal of Receptor and Signal Transduction Research"},{"key":"10.1016\/j.bbr.2013.01.034_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders","volume":"160","author":"Arborelius","year":"1999","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0330","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0167-0115(92)90514-U","article-title":"Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test","volume":"41","author":"Heilig","year":"1992","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.bbr.2013.01.034_bib0335","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0169-328X(93)90094-6","article-title":"Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus","volume":"18","author":"Suda","year":"1993","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1016\/j.bbr.2013.01.034_bib0340","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1210\/en.2005-1280","article-title":"Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake","volume":"147","author":"Smith","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0345","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/10253890701248673","article-title":"Neuropeptide S: a novel modulator of stress and arousal","volume":"10","author":"Okamura","year":"2007","journal-title":"Stress"},{"key":"10.1016\/j.bbr.2013.01.034_bib0350","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1037\/0735-7044.103.3.648","article-title":"Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats","volume":"103","author":"Takahashi","year":"1989","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0355","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02244208","article-title":"CRF antagonist reverses the \u201canxiogenic\u201d response to ethanol withdrawal in the rat","volume":"103","author":"Baldwin","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0360","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00652231","article-title":"Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide","volume":"88","author":"Swerdlow","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0365","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1258\/ebm.2010.009331","article-title":"Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety","volume":"235","author":"Thorsell","year":"2010","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"key":"10.1016\/j.bbr.2013.01.034_bib0370","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.12-06-02313.1992","article-title":"Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex","volume":"12","author":"Liang","year":"1992","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0375","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0306-4530(93)90043-K","article-title":"Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in rats","volume":"18","author":"Pich","year":"1993","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0380","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(86)90539-1","article-title":"Corticotropin releasing factor (CRF) receptor antagonist blocks activating and \u2018anxiogenic\u2019 actions of CRF in the rat","volume":"369","author":"Britton","year":"1986","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.034_bib0385","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1749-6632.1999.tb09273.x","article-title":"The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety","volume":"877","author":"Davis","year":"1999","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.bbr.2013.01.034_bib0390","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-2999(03)01282-2","article-title":"Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety","volume":"463","author":"Walker","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0395","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199305133281907","article-title":"Use of benzodiazepines in anxiety disorders","volume":"328","author":"Shader","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bbr.2013.01.034_bib0400","first-page":"188","article-title":"Knockdown of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease","volume":"13","author":"Horvath","year":"2011","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.bbr.2013.01.034_bib0405","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nn.2167","article-title":"Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance","volume":"11","author":"Tong","year":"2008","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.034_bib0410","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0028-3908(00)00010-1","article-title":"Neuropeptides \u2013 an overview","volume":"39","author":"Hokfelt","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.01.034_bib0415","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuron.2012.09.014","article-title":"Neuropeptide transmission in brain circuits","volume":"76","author":"van den Pol","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2013.01.034_bib0420","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modelling human depression and anxiety","volume":"4","author":"Cryan","year":"2005","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.bbr.2013.01.034_bib0425","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","article-title":"Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress","volume":"311","author":"Berton","year":"2006","journal-title":"Science"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:21:35Z","timestamp":1562631695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":85,"alternative-id":["S0166432813000533"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.01.034","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}